vs
太平洋生物科学（ASMB）与CSP INC（CSPI）财务数据对比。点击上方公司名可切换其他公司
CSP INC的季度营收约是太平洋生物科学的1.1倍（$12.0M vs $10.8M），CSP INC净利率更高（0.8% vs -85.2%，领先86.0%），太平洋生物科学同比增速更快（57.6% vs -23.2%），CSP INC自由现金流更多（$-3.0M vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
CSP Inc.是一家总部位于美国的科技企业，主营网络安全解决方案、托管IT服务、高性能计算系统及专业IT咨询服务，核心客户覆盖北美及部分国际市场的医疗、金融、制造、公共部门等领域的企业。
ASMB vs CSPI — 直观对比
营收规模更大
CSPI
是对方的1.1倍
$10.8M
营收增速更快
ASMB
高出80.8%
-23.2%
净利率更高
CSPI
高出86.0%
-85.2%
自由现金流更多
CSPI
多$12.2M
$-15.2M
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $12.0M |
| 净利润 | $-9.2M | $91.0K |
| 毛利率 | — | 39.3% |
| 营业利润率 | -100.9% | -0.9% |
| 净利率 | -85.2% | 0.8% |
| 营收同比 | 57.6% | -23.2% |
| 净利润同比 | 4.3% | -80.7% |
| 每股收益（稀释后） | $-0.72 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBCSPI
| Q4 25 | — | $12.0M | ||
| Q3 25 | $10.8M | $14.5M | ||
| Q2 25 | $9.6M | $15.4M | ||
| Q1 25 | $9.4M | $13.1M | ||
| Q4 24 | $7.4M | $15.7M | ||
| Q3 24 | $6.8M | $13.0M | ||
| Q2 24 | $8.5M | $13.1M | ||
| Q1 24 | $5.8M | $13.7M |
净利润ASMBCSPI
| Q4 25 | — | $91.0K | ||
| Q3 25 | $-9.2M | $-191.0K | ||
| Q2 25 | $-10.2M | $-264.0K | ||
| Q1 25 | $-8.8M | $-108.0K | ||
| Q4 24 | — | $472.0K | ||
| Q3 24 | $-9.6M | $-1.7M | ||
| Q2 24 | $-11.2M | $-185.0K | ||
| Q1 24 | $-9.1M | $1.6M |
毛利率ASMBCSPI
| Q4 25 | — | 39.3% | ||
| Q3 25 | — | 36.6% | ||
| Q2 25 | — | 28.8% | ||
| Q1 25 | — | 32.0% | ||
| Q4 24 | — | 29.1% | ||
| Q3 24 | — | 28.4% | ||
| Q2 24 | — | 35.0% | ||
| Q1 24 | — | 47.3% |
营业利润率ASMBCSPI
| Q4 25 | — | -0.9% | ||
| Q3 25 | -100.9% | -3.7% | ||
| Q2 25 | -115.2% | -7.9% | ||
| Q1 25 | -105.5% | -7.6% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | -160.1% | -15.7% | ||
| Q2 24 | -143.0% | -5.5% | ||
| Q1 24 | -185.5% | 9.0% |
净利率ASMBCSPI
| Q4 25 | — | 0.8% | ||
| Q3 25 | -85.2% | -1.3% | ||
| Q2 25 | -105.9% | -1.7% | ||
| Q1 25 | -93.6% | -0.8% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | -140.4% | -12.7% | ||
| Q2 24 | -130.7% | -1.4% | ||
| Q1 24 | -156.9% | 11.6% |
每股收益（稀释后）ASMBCSPI
| Q4 25 | — | $0.01 | ||
| Q3 25 | $-0.72 | $-0.02 | ||
| Q2 25 | $-1.33 | $-0.03 | ||
| Q1 25 | $-1.17 | $-0.01 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | $-1.51 | $-0.17 | ||
| Q2 24 | $-1.98 | $-0.02 | ||
| Q1 24 | $-1.66 | $0.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $24.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $44.8M |
| 总资产 | $240.0M | $69.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBCSPI
| Q4 25 | — | $24.9M | ||
| Q3 25 | $22.5M | $27.4M | ||
| Q2 25 | $24.0M | $26.3M | ||
| Q1 25 | $23.4M | $29.5M | ||
| Q4 24 | $38.3M | $30.7M | ||
| Q3 24 | $28.5M | $30.6M | ||
| Q2 24 | $19.2M | $28.9M | ||
| Q1 24 | $18.7M | $27.1M |
股东权益ASMBCSPI
| Q4 25 | — | $44.8M | ||
| Q3 25 | $182.7M | $44.6M | ||
| Q2 25 | $18.1M | $47.5M | ||
| Q1 25 | $27.1M | $47.5M | ||
| Q4 24 | $33.4M | $47.5M | ||
| Q3 24 | $26.0M | $47.3M | ||
| Q2 24 | $34.7M | $48.1M | ||
| Q1 24 | $32.6M | $48.2M |
总资产ASMBCSPI
| Q4 25 | — | $69.2M | ||
| Q3 25 | $240.0M | $71.2M | ||
| Q2 25 | $80.8M | $66.8M | ||
| Q1 25 | $99.0M | $67.1M | ||
| Q4 24 | $119.2M | $67.5M | ||
| Q3 24 | $100.3M | $69.4M | ||
| Q2 24 | $115.3M | $66.8M | ||
| Q1 24 | $119.9M | $64.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $-2.9M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $-3.0M |
| 自由现金流率自由现金流/营收 | -140.7% | -25.1% |
| 资本支出强度资本支出/营收 | 0.4% | 0.9% |
| 现金转化率经营现金流/净利润 | — | -32.04× |
| 过去12个月自由现金流最近4个季度 | — | $-2.8M |
8季度趋势，按日历期对齐
经营现金流ASMBCSPI
| Q4 25 | — | $-2.9M | ||
| Q3 25 | $-15.1M | $1.9M | ||
| Q2 25 | $-16.8M | $-3.3M | ||
| Q1 25 | $-23.4M | $1.9M | ||
| Q4 24 | $-51.1M | $1.7M | ||
| Q3 24 | $-15.2M | $-1.5M | ||
| Q2 24 | $-17.1M | $2.4M | ||
| Q1 24 | $-18.4M | $1.7M |
自由现金流ASMBCSPI
| Q4 25 | — | $-3.0M | ||
| Q3 25 | $-15.2M | $1.7M | ||
| Q2 25 | — | $-3.3M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | $-51.1M | $1.7M | ||
| Q3 24 | — | $-1.5M | ||
| Q2 24 | $-17.1M | $2.4M | ||
| Q1 24 | $-18.4M | $1.6M |
自由现金流率ASMBCSPI
| Q4 25 | — | -25.1% | ||
| Q3 25 | -140.7% | 11.5% | ||
| Q2 25 | — | -21.7% | ||
| Q1 25 | — | 14.5% | ||
| Q4 24 | -695.2% | 10.8% | ||
| Q3 24 | — | -11.7% | ||
| Q2 24 | -200.6% | 17.9% | ||
| Q1 24 | -317.7% | 11.9% |
资本支出强度ASMBCSPI
| Q4 25 | — | 0.9% | ||
| Q3 25 | 0.4% | 1.6% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.4% | 0.3% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | 0.2% | 0.3% | ||
| Q1 24 | 0.2% | 0.1% |
现金转化率ASMBCSPI
| Q4 25 | — | -32.04× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.69× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASMB
暂无分部数据
CSPI
| Products | $6.7M | 56% |
| Services | $5.3M | 44% |
